Following on from our theme of roads and getting places, I’d like to take you on a world tour highlighting several research papers that have studied the importance of breast density.
In this interview, Kylie Chandler, Product On-Boarding and Clinical Specialist at Volpara, explains the how Volpara’s software removes subjectivity, while improving consistency and quality.
You may not be familiar with Yogi Berra, a famous American baseball player, but you may have heard some of his famous quotes and even the claim that a cartoon...
In this interview, Dr Ralph Highnam, CEO provides insight into the FY2018 results and outlines the Company’s goals for FY2019.
Breast density is a hot topic in Australia right now, as it should be—international research has shown that women with dense breasts have a significant increase in the risk of...
When Volpara Health Technologies first commenced operations, we were a traditional medical device company—we built software products, sold them and then went back to the purchaser when we had something...
In this video, Imaging Associates Radiologist and Clinical Director Dr Daniel Lee discusses the positive impact of VolparaEnterprise on the group’s radiology and imaging services.
Cancer is the ultimate egalitarian, anyone is susceptible. This makes it the most fascinating of subjects.
Two weeks ago, about 50 000 attendees descended on Chicago for the biggest medical imaging meeting in the world—the 103rd annual meeting of the Radiological Society of North America (RSNA 2017).
Associate Professor Gelareh Farshid, of BreastScreen South Australia has released a perspective supporting routine reporting of breast density in the Australian breast screening program.